Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Metabolic reprogramming promotes ADPKD cystogenesis

July 22, 2020

Goldfinch Bio begins phase IIa study of GFB-887 for renal diseases

July 21, 2020

Apolipoprotein L1 inhibitors discovered at Vertex Pharmaceuticals

July 15, 2020

Phase III FIDELIO-DKD study of finerenone meets primary endpoint

July 10, 2020

Japanese approval for Samsca for hyponatremia secondary to SIADH in adults

July 1, 2020

Initiator Pharma obtains U.K. approval to begin phase IIa study of IP-2018

June 30, 2020

SCOHIA initiates phase II study of SCO-792 in diabetic kidney disease

June 26, 2020

New renal imaging agent for the measurement of glomerular filtration rate

June 22, 2020

FDA approves Crysvita for tumor-induced osteomalacia

June 19, 2020

Danish Medical Agency approves CTA application for AP-1189 in nephrotic syndrome

June 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...